Senvest Capital
Headquartered in Montreal, Canada, Senvest Capital operates as a holding company with interests in investment management and direct investing in public securities and private investments. Senvest, publicly traded since 1971 and presently listed on the Toronto Stock Exchange, was originally founded as the exclusive Canadian licensee and distributor for US-based Sensormatic Electronics, a pioneer in anti-theft-at-retail electronic security systems. Among other businesses acquired and operated by the company, Senvest Capital also spearheaded the development and operated one of Canada’s first cable pay-TV channels, First Choice, which it sold to a leading Canadian media company Astral Media.
Bigfoot Biomedical is a medical device company changing diabetes care for people with insulin-requiring diabetes. The company developing an end-to-end type 1 diabetes management system using a simple design, cloud connectivity, and human-centered automation. It optimizes the dosing and delivery of insulin through an integrated medical device ecosystem powered by machine learning and enhanced by secure, user-friendly consumer technologies, fundamentally changing the paradigm of care. Biofoot Biomedical ’s pioneering smartphone-enabled systems include both automated infusion pump and connected insulin pen options for consumers and will be delivered via a first-of-its-kind monthly subscription service model. By employing data-driven intelligence across an integrated device ecosystem, they are transforming diabetes care with a fully comprehensive digital drug delivery platform experienced as a service.
Bigfoot Biomedical is a medical device company changing diabetes care for people with insulin-requiring diabetes. The company developing an end-to-end type 1 diabetes management system using a simple design, cloud connectivity, and human-centered automation. It optimizes the dosing and delivery of insulin through an integrated medical device ecosystem powered by machine learning and enhanced by secure, user-friendly consumer technologies, fundamentally changing the paradigm of care. Biofoot Biomedical ’s pioneering smartphone-enabled systems include both automated infusion pump and connected insulin pen options for consumers and will be delivered via a first-of-its-kind monthly subscription service model. By employing data-driven intelligence across an integrated device ecosystem, they are transforming diabetes care with a fully comprehensive digital drug delivery platform experienced as a service.
Bigfoot Biomedical is a medical device company changing diabetes care for people with insulin-requiring diabetes. The company developing an end-to-end type 1 diabetes management system using a simple design, cloud connectivity, and human-centered automation. It optimizes the dosing and delivery of insulin through an integrated medical device ecosystem powered by machine learning and enhanced by secure, user-friendly consumer technologies, fundamentally changing the paradigm of care. Biofoot Biomedical ’s pioneering smartphone-enabled systems include both automated infusion pump and connected insulin pen options for consumers and will be delivered via a first-of-its-kind monthly subscription service model. By employing data-driven intelligence across an integrated device ecosystem, they are transforming diabetes care with a fully comprehensive digital drug delivery platform experienced as a service.
UNLIMITED is at the forefront in the design and creation of high-end Virtual Reality Experiences. VR is a revolutionary new medium - a mind-blowing hybrid between interactive media and immersive cinematic experiences. They offer branded and original VR content for immersive and interactive media, including films, TV series, games and advertising.
Bigfoot Biomedical is a medical device company changing diabetes care for people with insulin-requiring diabetes. The company developing an end-to-end type 1 diabetes management system using a simple design, cloud connectivity, and human-centered automation. It optimizes the dosing and delivery of insulin through an integrated medical device ecosystem powered by machine learning and enhanced by secure, user-friendly consumer technologies, fundamentally changing the paradigm of care. Biofoot Biomedical ’s pioneering smartphone-enabled systems include both automated infusion pump and connected insulin pen options for consumers and will be delivered via a first-of-its-kind monthly subscription service model. By employing data-driven intelligence across an integrated device ecosystem, they are transforming diabetes care with a fully comprehensive digital drug delivery platform experienced as a service.
Spotify is a commercial music streaming service that provides restricted digital content from a range of record labels and artists. Users can browse through the interface by artist, album, genre, playlist, record label, and direct searches. It also enables individuals to create, share, and edit playlists with other users. If users want recommendations, they can integrate their system with Last.fm, an application that provides music recommendations based on listening history. The radio feature installed in Spotify creates random playlists for its users that are related to preferred artists. Spotify is available for mobile device platforms such as Android, Blackberry, Boxee, iOS, Linux, MeeGo, Squeezebox, Windows mobile, and more.
Medigus Ltd. is a medical device company based in Omer, Israel, that specializes in developing and marketing innovative minimally invasive endo-surgical tools and direct visualization technology. Founded in 1999, the company primarily focuses on the treatment of gastroesophageal reflux disease (GERD), a common chronic condition. Medigus has created an endoscopic system known as the SRS, which integrates a miniaturized video camera, surgical stapler, and ultrasonic alignment sights into a single device. This system allows gastroenterologists and surgeons to perform a partial anterior fundoplication endoluminally, significantly transforming GERD treatment by reducing reliance on traditional open or laparoscopic surgeries. In addition to its proprietary products, Medigus designs and manufactures endoscopy systems for partner companies, offering a range of technologies including small video cameras, video processors, and various types of endoscopes for diverse endoscopic procedures. The company operates globally across the United States, Europe, Asia, and other international markets.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.